A detailed history of Td Waterhouse Canada Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Td Waterhouse Canada Inc. holds 202,698 shares of NVO stock, worth $17.7 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
202,698
Previous 188,251 7.67%
Holding current value
$17.7 Million
Previous $27.4 Billion 12.98%
% of portfolio
0.19%
Previous 0.25%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$119.07 - $145.42 $1.72 Million - $2.1 Million
14,447 Added 7.67%
202,698 $23.9 Billion
Q2 2024

Nov 12, 2024

BUY
$122.71 - $146.91 $7.09 Million - $8.49 Million
57,773 Added 44.28%
188,251 $27.4 Billion
Q2 2024

Aug 02, 2024

BUY
$122.71 - $146.91 $9,448 - $11,312
77 Added 0.06%
130,478 $21.9 Billion
Q1 2024

May 10, 2024

BUY
$102.11 - $135.92 $3.55 Million - $4.72 Million
34,738 Added 36.31%
130,401 $19.9 Billion
Q4 2023

Feb 12, 2024

BUY
$87.78 - $105.45 $2.2 Million - $2.65 Million
25,109 Added 35.59%
95,663 $12.5 Billion
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $4.17 Million - $9.15 Million
45,847 Added 185.56%
70,554 $7.77 Billion
Q2 2023

Nov 13, 2023

SELL
$155.98 - $172.65 $1.31 Million - $1.45 Million
-8,378 Reduced 25.32%
24,707 $4.07 Billion
Q1 2023

Nov 13, 2023

SELL
$132.34 - $159.14 $80,330 - $96,597
-607 Reduced 1.8%
33,085 $5.48 Billion
Q4 2022

Nov 13, 2023

SELL
$102.55 - $135.33 $66,247 - $87,423
-646 Reduced 1.88%
33,692 $4.8 Billion
Q3 2022

Nov 13, 2023

SELL
$95.28 - $116.93 $166,168 - $203,925
-1,744 Reduced 4.83%
34,338 $3.65 Billion
Q2 2022

Nov 13, 2023

BUY
$103.24 - $121.81 $111,602 - $131,676
1,081 Added 3.09%
36,082 $4.12 Billion
Q1 2022

Nov 13, 2023

SELL
$93.1 - $112.54 $1.16 Million - $1.41 Million
-12,490 Reduced 26.3%
35,001 $4.04 Billion
Q4 2021

Nov 13, 2023

BUY
$95.88 - $117.08 $4.55 Million - $5.56 Million
47,491 New
47,491 $5.11 Billion

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Td Waterhouse Canada Inc. Portfolio

Follow Td Waterhouse Canada Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Waterhouse Canada Inc., based on Form 13F filings with the SEC.

News

Stay updated on Td Waterhouse Canada Inc. with notifications on news.